Stock Events

Stock Events

Daebongls 

₩7,880
2
-₩100-1.25% Friday 06:30

Statistics

Day High
7,880
Day Low
7,880
52W High
13,890
52W Low
6,780
Volume
-
Avg. Volume
-
Mkt Cap
87.37B
P/E Ratio
-
Dividend Yield
0.63%
Dividend
50

Upcoming

Dividends

0.63%Dividend Yield
Apr 26
₩50
Feb 25
₩50
Apr 24
₩50
Apr 23
₩50
Apr 22
₩50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26FebExpected
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q1 2024
Q2 2024
Q4 2025
87.2
126.42
165.64
204.86
Expected EPS
N/A
Actual EPS
N/A

Financials

9.86%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
102.06BRevenue
10.06BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Celltrion Pharm
068760.KQ
Mkt Cap1.74T
Celltrion Pharm Inc. competes in the pharmaceutical sector focusing on the development and manufacturing of drugs, similar to Daebongls.
Seegene
096530.KQ
Mkt Cap1.3T
SillaJen Inc. focuses on biopharmaceuticals, particularly in the therapeutic area, which aligns with Daebongls' market interests.
Ildong Pharm
249420.KQ
Mkt Cap0
MedPacto Inc. is engaged in the biopharmaceutical field, developing therapeutic drugs that compete with Daebongls' offerings.
Neopharm
092730.KQ
Mkt Cap296.4B
Chong Kun Dang Pharmaceutical Corp. manufactures and sells pharmaceutical products, competing in the same market segments as Daebongls.

About

Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt powder, jeju active complex, and ginseng flower extract; and natural and synthesis cosmetics like moisturizing, skin protection, whitening, anti- aging, skin care, and hair care products. The company's Pharmaceutical Raw Material division develops the API of respiratory, hypertension, digestive-system treatments, and medicines and supply excipients to domestic companies as an agent for global companies. The company's Food & Feed division manufactures and distributes functional additives, protein products, amino acids, and vitamins. Daebongls.Co.,Ltd. was founded in 1986 and is headquartered in Incheon, South Korea.
Show more...
CEO
Mr. Jin-Oh Park
Employees
123
Country
South Korea
ISIN
KR7078140001

Listings

KQ
KR
078140.KQ

0 Comments

Share your thoughts

FAQ

What is Daebongls stock price today?▼
The current price of 078140.KQ is ₩7,880 KRW — it has decreased by -1.25% in the past 24 hours. Watch Daebongls stock price performance more closely on the chart.
What is Daebongls stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Daebongls stocks are traded under the ticker 078140.KQ.
Is Daebongls stock price growing?▼
078140.KQ stock has fallen by -4.37% compared to the previous week, the month change is a -3.19% fall, over the last year Daebongls has showed a -41.89% decrease.
What is Daebongls market cap?▼
Today Daebongls has the market capitalization of 87.37B
What is Daebongls revenue for the last year?▼
Daebongls revenue for the last year amounts to 102.06B KRW.
What is Daebongls net income for the last year?▼
078140.KQ net income for the last year is 10.06B KRW.
Does Daebongls pay dividends?▼
Yes, 078140.KQ dividends are paid annual. The last dividend per share was 50 KRW. As of today, Dividend Yield (FWD)% is 0.63%.
How many employees does Daebongls have?▼
As of September 05, 2026, the company has 123 employees.
In which sector is Daebongls located?▼
Daebongls operates in the Materials sector.
When did Daebongls complete a stock split?▼
The last stock split for Daebongls was on March 30, 2011 with a ratio of 1:1.
Where is Daebongls headquartered?▼
Daebongls is headquartered in Incheon, South Korea.